A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 2, Pages 147
Publisher
MDPI AG
Online
2019-01-29
DOI
10.3390/cancers11020147
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients
- (2019) Xian Hua Gao et al. International Journal of Clinical Oncology
- Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer
- (2018) Rona Yaeger et al. CANCER CELL
- Cancer secretome and inflammation: The bright and the dark sides of NF-κB
- (2018) Daria Capece et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF V600E -Mutant Colorectal Cancer
- (2018) Ryan B. Corcoran et al. Cancer Discovery
- Clinical application of targeted next-generation sequencing for colorectal cancer patients: a multicentric Belgian experience
- (2018) Nicky D’Haene et al. Oncotarget
- Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer
- (2018) Francesca De Nicola et al. Oncogenesis
- Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma
- (2017) Fernando Rivera et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Next-generation sequencing: recent applications to the analysis of colorectal cancer
- (2017) Filippo Del Vecchio et al. Journal of Translational Medicine
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Comprehensive genomic sequencing detects important genetic differences between right-sided and left-sided colorectal cancer
- (2017) Yoshifumi Shimada et al. Oncotarget
- Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer
- (2017) Sabine Tejpar et al. JAMA Oncology
- Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples
- (2016) Ashraf Dallol et al. Journal of Translational Medicine
- From tumour heterogeneity to advances in precision treatment of colorectal cancer
- (2016) Cornelis J. A. Punt et al. Nature Reviews Clinical Oncology
- A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC
- (2016) Michael J. Schell et al. Nature Communications
- Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer
- (2015) Francesca Belardinilli et al. CLINICAL BIOCHEMISTRY
- Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment andRASMutations in Colorectal Cancer
- (2015) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- First-line chemotherapy for mCRC—a review and evidence-based algorithm
- (2015) Chiara Cremolini et al. Nature Reviews Clinical Oncology
- Circulating tumor cells
- (2014) Cristina Raimondi et al. CANCER BIOLOGY & THERAPY
- Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer
- (2014) Carlo Capalbo et al. CANCER BIOLOGY & THERAPY
- Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients
- (2014) Umberto Malapelle et al. JOURNAL OF CLINICAL PATHOLOGY
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
- (2014) Volker Heinemann et al. LANCET ONCOLOGY
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
- (2010) Alberto Bardelli et al. JOURNAL OF CLINICAL ONCOLOGY
- KRASandBRAFMutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
- (2009) Susan D. Richman et al. JOURNAL OF CLINICAL ONCOLOGY
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of tumor microsatellite instability in laryngeal cancer using five quasimonomorphic mononucleotide repeats and pentaplex PCR
- (2008) M Różańska-Kudelska et al. Advances in Medical Sciences
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
- Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
- (2008) Carsten Bokemeyer et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started